BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17028108)

  • 1. Platelets and heart failure.
    Chung I; Lip GY
    Eur Heart J; 2006 Nov; 27(22):2623-31. PubMed ID: 17028108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure, platelet activation and inhibition of the renin-angiotensin-aldosterone system.
    Bauersachs J; Schäfer A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):889-93. PubMed ID: 15521482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A role of activation of proinflammatory cytokines and production of autoimmune complexes in the pathogenesis of chronic heart failure in patients with postinfarct cardiac dysfunction].
    Tepliakov AT; Debirov MM; Bolotskaia LA; Stepacheva TA; Rybal'chenko EV; Karaman NV
    Klin Med (Mosk); 2004; 82(8):15-20. PubMed ID: 15468717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation in heart failure.
    Schäfer A; Eigenthaler M; Bauersachs J
    Clin Lab; 2004; 50(9-10):559-66. PubMed ID: 15481631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden death in heart failure: vascular or electrical?
    Cleland JG; Massie BM; Packer M
    Eur J Heart Fail; 1999 Mar; 1(1):41-5. PubMed ID: 10937978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic heart failure: a prothrombotic state.
    de Peuter OR; Kok WE; Torp-Pedersen C; Büller HR; Kamphuisen PW
    Semin Thromb Hemost; 2009 Jul; 35(5):497-504. PubMed ID: 19739040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart failure and cachexia].
    Tabet JY; Meurin P; Ben Driss A; Logeart D; Héliès-Toussaint C; Tartière JM; Cohen-Solal A; Grynberg A; Bourdel-Marchasson I
    Arch Mal Coeur Vaiss; 2006 Dec; 99(12):1203-9. PubMed ID: 18942522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of heart failure.
    Ecder T; Korular D; Gurevich AK; Weinberger HD; Schrier RW
    Curr Opin Investig Drugs; 2001 Jan; 2(1):81-6. PubMed ID: 11527017
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction.
    Chirkov YY; Holmes AS; Martelli JD; Horowitz JD
    Am J Cardiol; 2004 Jun; 93(11):1438-40, A10. PubMed ID: 15165936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation in acute, decompensated congestive heart failure.
    Chung I; Choudhury A; Lip GY
    Thromb Res; 2007; 120(5):709-13. PubMed ID: 17287016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta blockade plus NO release. Patients with heart failure can be loaded more].
    MMW Fortschr Med; 2002 Oct; 144(41):57. PubMed ID: 12474368
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart failure.
    McKelvie R
    Clin Evid; 2004 Jun; (11):122-48. PubMed ID: 15652002
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental options in the treatment of heart failure: the role of cytokine antagonism.
    Kalra D; Bozkurt B; Deswal A; Torre-Amione G; Mann DL
    Heart Fail Monit; 2001; 1(4):114-21. PubMed ID: 12634895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
    Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG
    Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of heart failure and preserved systolic function].
    Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
    Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and management of heart failure in the outpatient setting.
    Wilbur J; James P
    Prim Care; 2005 Dec; 32(4):1115-29, ix. PubMed ID: 16326230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.